DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» GM2 gangliosidoses
GM2 gangliosidoses
Sphingolipid Metabolism Diseases ⁎ Thomas Kolter, Konrad Sandhoff
N-Acetyl-L-Leucine Improves Functional Recovery and Attenuates Cortical Cell
GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies
Mouse Model of GM2 Activator Deficiency Manifests Cerebellar Pathology and Motor Impairment
References and Further Reading
Prevalence of Lysosomal Storage Diseases in Portugal
INAUGURAL-DISSERTATION Zur Erlangung Des Doktorgrades Der Medizin
Early Differential Diagnosis of Infantile Neuronal Ceroid Lipofuscinosis, Rett Syndrome, and Krabbe Disease by CT and MR
Late-Onset Tay-Sachs Disease: Phenotypic Characterization and Genotypic Correlations in 21 Affected Patients Orit Neudorfer1, Gregory M
Disorders of Sphingolipid Synthesis, Sphingolipidoses, Niemann-Pick Disease Type C and Neuronal Ceroid Lipofuscinoses
Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease
A Possible Biomarker of Neurocytolysis in Infantile Gangliosidoses: Aspartate Transaminase
Prenatal Diagnosis of GM2 Gangliosidosis with High
A Rare Case of Sandhoff Disease: Two in the Same Family
Us 2018 / 0305689 A1
Abnormal Sphingolipid World in Inflammation Specific for Lysosomal
Consensus Clinical Management Guidelines for Niemann-Pick
Diagnosis of Inherited Metabolic Disorders Affecting the Nervous System
Top View
PEX6: an Imaging Overlap Between Peroxisomal and Lysosomal Storage Diseases
Update on Neuropathies in Inborn Errors of Metabolism
Characterization of a New Model of GM2-Gangliosidosis (Sandhoff's Disease) in Korat Cats
38 Disorders of Sphingolipid Metabolism
A Master Protocol to Investigate a Novel Therapy Acetyl-L-Leucine for Three Ultra-Rare Neurodegenerative Diseases: Niemann-Pick
GM2 Gangliosidosis: Clinical Features and Current Therapies
Lysosomal Lipid Storage Diseases
Principles of Molecular and Metabolic Pathogenesis
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
GM2 Gangliosidoses?
Molecular Basis of Adult-Onset and Chronic GM2
A Master Protocol to Investigate a Novel Therapy Acetyl-L-Leucine for Three Ultra-Rare
Lysosomal Storage Diseases Carlos Ferreira George Washington University
Lysosomal Storage Diseases
GM2 Activator Protein Deficiency, Mimic of Tay-Sachs Disease
Neuronal Ceroid Lipofuscinosis (Batten's Disease) N
(ADLL) in a Mouse Model of Sandhoff Disease
B1 Variant of GM2 Gangliosidosis in a 12-Year
Institute of Anatomy and Biology, Philadelphia, Pennsylvania. Fusion